PDHA1

Item Information
Catalog #
Size
Price
Description

The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Product Overview
Entrez GenelD
5160
Aliases
PDHA; PDHAD; PHE1A; PDHCE1A
Clone#
4E12D6
Host / Isotype
Mouse / Mouse IgG2a
Species Reactivity
Human, Mouse, Rat
Immunogen
Purified recombinant fragment of human PDHA1(AA: 241-390) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4℃; -20℃ for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
ICC (Immunocytochemistry)
1/50 - 1/200
FCM (Flow Cytometry)
1/200 - 1/400
ELISA
1/10000
References
1.Eur J Paediatr Neurol. 2021 Mar;31:27-30.
2.Pathol Res Pract. 2019 Mar;215(3):478-482.
Product Image
Elisa
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Western Blot
Figure 2:Western blot analysis using PDHA1 mAb against human PDHA1 (AA: 241-390) recombinant protein. (Expected MW is 37.5 kDa)
Figure 2:Western blot analysis using PDHA1 mAb against human PDHA1 (AA: 241-390) recombinant protein. (Expected MW is 37.5 kDa)
Western Blot
Figure 3:Western blot analysis using PDHA1 mAb against HEK293-6e (1) and PDHA1 (AA:241-390)-hIgGFc transfected HEK293-6e (2) cell lysate.
Figure 3:Western blot analysis using PDHA1 mAb against HEK293-6e (1) and PDHA1 (AA:241-390)-hIgGFc transfected HEK293-6e (2) cell lysate.
Western Blot
Figure 4:Western blot analysis using PDHA1 mouse mAb against HepG2 (1),Hek293 (2),HL-60 (3),SK-OV-3 (4),PC-3 (5),PANC-1 (6),NRK (7),C2C12 (8), C6 (9), and PC-12 (10) cell lysate.
Figure 4:Western blot analysis using PDHA1 mouse mAb against HepG2 (1),Hek293 (2),HL-60 (3),SK-OV-3 (4),PC-3 (5),PANC-1 (6),NRK (7),C2C12 (8), C6 (9), and PC-12 (10) cell lysate.
Immunohistochemical analysis
Figure 5:Immunofluorescence analysis of Hela cells using PDHA1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Figure 5:Immunofluorescence analysis of Hela cells using PDHA1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Immunohistochemical analysis
Figure 6:Immunofluorescence analysis of NIH/3T3 cells using PDHA1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Figure 6:Immunofluorescence analysis of NIH/3T3 cells using PDHA1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Immunofluorescence analysis
Figure 7:Flow cytometric analysis of Hela cells using PDHA1 mouse mAb (green) and negative control (red).
Figure 7:Flow cytometric analysis of Hela cells using PDHA1 mouse mAb (green) and negative control (red).
Immunohistochemical analysis
Figure 8:Immunohistochemical analysis of paraffin-embedded lung cancer tissues using PDHA1 mouse mAb with DAB staining.
Figure 8:Immunohistochemical analysis of paraffin-embedded lung cancer tissues using PDHA1 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 9:Immunohistochemical analysis of paraffin-embedded colon cancer tissues using PDHA1 mouse mAb with DAB staining.
Figure 9:Immunohistochemical analysis of paraffin-embedded colon cancer tissues using PDHA1 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 10:Immunohistochemical analysis of paraffin-embedded breast cancer tissues using PDHA1 mouse mAb with DAB staining.
Figure 10:Immunohistochemical analysis of paraffin-embedded breast cancer tissues using PDHA1 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 11:Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using PDHA1 mouse mAb with DAB staining.
Figure 11:Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using PDHA1 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 12:Immunohistochemical analysis of paraffin-embedded mouse kidney tissues using PDHA1 mouse mAb with DAB staining.
Figure 12:Immunohistochemical analysis of paraffin-embedded mouse kidney tissues using PDHA1 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 13:Immunohistochemical analysis of paraffin-embedded Rat kidney tissues using PDHA1 mouse mAb with DAB staining.
Figure 13:Immunohistochemical analysis of paraffin-embedded Rat kidney tissues using PDHA1 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 14:Immunohistochemical analysis of paraffin-embedded Rabbit kidney tissues using PDHA1 mouse mAb with DAB staining.
Figure 14:Immunohistochemical analysis of paraffin-embedded Rabbit kidney tissues using PDHA1 mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.